LOGC - LogicBio Therapeutics - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LogicBio Therapeutics's activity chart (see below) currently has 13 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75% with an average time for these price targets to be met of 265 days.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 22-Aug-2022.

Best performing analysts who are covering LOGC - LogicBio Therapeutics:

Silvan Tuerkcan Gena Wang Yasmeen Rahimi Geulah Livshits

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Geulah Livshits (CHARDAN CAPITAL)

Buy Since 24-Dec-2021

Please subscribe to see extended stock data

Silvan Tuerkcan (JMP)

Buy

$-5.93 (-74.78%)

$16

Please subscribe to see extended stock data

Gena Wang (BARCLAYS)

Buy

$5.93 (286.47%)

Please subscribe to see extended stock data

Yasmeen Rahimi (PIPER SANDLER)

$26

$17.37 (201.27%)

Please subscribe to see extended stock data

Show more analysts

Load Price Targets and Ratings Chart

Please expand the browser size to see the chart

What is LOGC (LogicBio Therapeutics) average time for price targets to be met?

On average it took 265 days on average for the stock forecasts to be realized with a an average price target met ratio 75

Which analyst has the current highest performing score on LOGC (LogicBio Therapeutics) with a proven track record?

SILVAN TUERKCAN

Which analyst has the current lower performing score on LOGC (LogicBio Therapeutics) with a proven track record?

GEULAH LIVSHITS

Which analyst has the most public recommendations on LOGC (LogicBio Therapeutics)?

Silvan Tuerkcan works at JMP and has 42 price targets and 29 ratings on LOGC

Which analyst is the currently most bullish on LOGC (LogicBio Therapeutics)?

Yasmeen Rahimi with highest potential upside - $17.37

Which analyst is the currently most reserved on LOGC (LogicBio Therapeutics)?

Silvan Tuerkcan with lowest potential downside - -$5.93